Announcements & Circulars-Consun Pharmaceutical Group

Home
Approach To Consun
Company profile Management team Business Structure
Product Center
Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
R&D Innovation
R&D Platform R&D Team R&D Technology R&D Achievements
Investor Relations
Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact

中文

Investor Relations

Corporate Governance
Announcements & Circulars
Regular Reports
Documents available for inspection
IR Contact

Announcements & Circulars

2020-01-17 Next Day Disclosure Return
2020-01-16 Next Day Disclosure Return
2020-01-15 Next Day Disclosure Return
2020-01-14 Next Day Disclosure Return
2020-01-13 Next Day Disclosure Return
2020-01-10 Next Day Disclosure Return
2020-01-09 PROFIT ALERT
2020-01-01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
2019-12-23 Next Day Disclosure Return
2019-12-01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2019

Home Previous 34 35 36 37 383940 41 42 43 44 ...69 Next Last

Approach To Consun
Product Center
R&D Innovation
Investor Relations

400-930-1681

总机：（86）20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

Consun
Health Station
Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号 Design: uweb